Search results
Aptose Biosciences (APTO) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 7 hours agoAptose Biosciences (APTO) might move higher on growing optimism about its earnings prospects, which...
Docebo (NASDAQ:DCBO) Receives Buy Rating from Needham & Company LLC
ETF DAILY NEWS· 19 hours agoNeedham & Company LLC reaffirmed their buy rating on shares of Docebo (NASDAQ:DCBO – Free Report) in a research note published on Wednesday morning, Benzinga reports. The ...
Canaccord maintains Buy rating on Quanterix stock amid AD drug news By Investing.com
Investing.com· 1 day agoOn Wednesday, Canaccord Genuity sustained its Buy rating and $25.00 price target for Quanterix Corp...
Legal & General Group Plc (LON:LGEN) Receives Average Rating of “Buy” from Brokerages
ETF DAILY NEWS· 13 hours agoLegal & General Group Plc (LON:LGEN – Get Free Report) has earned an average recommendation of “Buy” from the five research firms that are covering the company, Marketbeat ...
Jim Cramer says it's still too early to buy Nike — but he likes these 3 stocks
CNBC· 8 hours agoKimberly-Clark : Bank of America double upgraded the Kleenex parent's stock to buy from a...
The best Bluetooth speakers
NBC Universal via AOL· 1 hour agoSelect independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. There’s something fun...
Stifel lifts price target, retains Buy rating on NetApp shares By Investing.com
Investing.com· 1 day agoOn Wednesday, Stifel updated its financial outlook on NetApp (NASDAQ:NTAP), a leading data...
1 Wall Street Analyst Says Apple Could Hit $230. Is It a Buy?
Motley Fool via Yahoo Finance· 8 hours agoOne Wall Street analyst is also jumping on the bandwagon. Image source: Getty Images. Bank of...
Oxford Metrics (LON:OMG) Receives “Buy” Rating from Canaccord Genuity Group
ETF DAILY NEWS· 19 hours agoCanaccord Genuity Group reaffirmed their buy rating on shares of Oxford Metrics (LON:OMG – Free Report) in a report published on Wednesday morning, Marketbeat reports. They ...
GSK’s (GSK) “Buy” Rating Reiterated at Shore Capital
ETF DAILY NEWS· 19 hours agoShore Capital reissued their buy rating on shares of GSK (LON:GSK – Free Report) in a report published on Wednesday morning, Marketbeat reports. GSK has been the topic of ...
